News from NORD

NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans


 

NORD has joined several other patient organizations in voicing opposition to proposed expansion of short-term, limited-duration health plans. NORD and its advocacy partners believe that expanding these plans would destabilize the insurance marketplace and increase premiums for those who are in the greatest need of care. For information, view the coalition letter to Congress here and letter to the Administration here .

Recommended Reading

MDS Foundation Hosts Family/Caregiver Forums
MDedge Hematology and Oncology
‘Right to try’ bill passes House
MDedge Hematology and Oncology
Think about breast cancer surveillance for transgender patients
MDedge Hematology and Oncology
Lenalidomide yields responses in a rare cutaneous lymphoma
MDedge Hematology and Oncology
MDedge Daily News: Which nonopioids are ripe for abuse?
MDedge Hematology and Oncology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Hematology and Oncology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Hematology and Oncology
RFPs Available for the Study of Three Rare Diseases
MDedge Hematology and Oncology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Hematology and Oncology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Hematology and Oncology